The Medical Director


Contact Info


Executive Secretary Elena Malekkidou

As Director of the Medical Council of the GOC, Prof. Nikolaos Zamboglou coordinates the medical activities of all Departments. With a long and successful career in Germany, his dream was to return one day to his homeland and offer to all citizens of Cyprus, with the experience, know-how, and the highly qualified and trained scientific staff that he chose, the same level of services and care that he had known and applied for almost 50 years in what he regards as his “second homeland”.

According to the latest statistics, the rate of new cases of cancer is increasing year by year. There are many reasons for this: the aging of the population, the way of life (tobacco, alcohol, poor diet, lack of physical activity, being overweight, etc), environmental factors, sun exposure, maybe even the genes in some cases (i.e. family history), and certainly, on the other hand, the fact that due to many and better diagnostic methods, we are now detecting mor cancer cases.

The good news however is that more and more malignancies, once detected in early stages, can be cured.

Of course, being able to apply and practice coordinated oncological methods/treatments, under the same roof, in collaboration with Medical Oncology, Radiotherapy and Advanced Brachytherapy, and with the help of all modern imaging and diagnostic methods, we can achieve optimal results, maintain at the same time a good quality of life for our patients. The atter, is fundamental to us.

Progress and breakthroughs in cancer research worldwide are fascinating. A modern and advanced oncology center cannot just follow and monitor these developments, but should also participate in them: Take part in the research.

Thus, right from the beginning we established the new Cancer Research Center with the Cyprus University of Technology (TEPAK). This creates excellent conditions and fertile ground for our scientific endeavour into cancer treatments with our academic partners.

The transmission of knowledge to the new generation is a duty for the experienced. The cooperation with the European University and the acknowledgment of the GOC as a University Clinic, will certainly broaden our horizons, and will allow us to transfer and share our knowledge in the scientific and practical treatments of cancer. Always for the benefit of the patient.

Our goal is excellence. Our guide, the constant reminder and wake-up-call that “we can always do something better”.

Nikolaos Zamboglou
More about Dr. Zamboglou


Prof. Nikolaos Zamboglou was born in Limassol in 1949 where he finished school.

  • Education – Academic
  • Professional Experience
  • Clinical Applications
  • Awards
  • After having received a DAAD (Deutscher Akademischer Austausch Dienst) scholarship, he studied Physics at the Technical University of Aachen and received his degree Dipl. Phys. (MSc) in 1974.
  • From 1974 – 1977 he conducted his graduate thesis and received the degree Dr. rer. nat. (PhD in Physics) at the Department of Nuclear Research KFA Jülich at the University of Düsseldorf after being granted a KFA scholarship.
  • 1979 – 1985: Medical studies at the Medical School of the University of Essen.
  • 1985: Degree MD. During the same period of time he was research fellow at the Institute of Radiobiology and Medical Physics at the University of Essen.
  • 1985 – 1986: Resident in Radiation – Oncology at the Alfried Krupp Hospital in Essen.
  • 1986 – 1989: Completion of his residency program in Radiation – Oncology at the University Hospital Düsseldorf, Germany.
  • 1987: Doctoral degree Dr. med (PhD in Medicine) from the Medical School of the University of Essen.
  • 1989: Associated Professor in Radiation Oncology (Priv. Doz.).


Dr.. Zamboglou has contributed 137 publications in renowned German and international scientific journals with approximately 1.200 citations. His academic work included also the editing and authorship of 7 books as well as 23 book-chapters in the field of oncology.

During the 70´s in his capacity as a physicist at the KFA Jülich (Centre for Nuclear Research Jülich) and the Institute of Medical Physics and Radiation of the University of Essen, he focused his work on the topic of biological dosimetry. In the 80´s he also expanded his research activities on the field of simultaneous radio-chemotherapy and implemented the results of his translational research at the University Hospital of Düsseldorf.

  • 1990 – 1992: Senior attending physician at the Department of Radiation Oncology of the University of Düsseldorf.
  • 1992:* Head of Department and Professor of Radiation – Oncology at the Department of Radiotherapy of the Offenbach Hospital, teaching hospital of the Johann Wolfgang Goethe University of Frankfurt.
  • 1993: Adjunct Research Professor at the National Technical University of Athens at the Institute of Communication and Computer Systems.
  • 2001 – 2007: Member of the Board of Directors of the German Society of Radiation Oncology (DEGRO).
  • 2003 – 2005: President of the German Society of Radiation Oncology (DEGRO).
  • 2017 – Today: Founder, Medical Director and CEO of the German Oncology Center in Cyprus

(*) After becoming Head of the Department of Radiation Oncology at the Offenbach Hospital in 1992, he focused on clinical as well as technological studies in the field of interventional radiotherapy – brachytherapy.
His collaboration with Prof N. Uzunoglou from the National Technical University of Athens, Professor G. Sakas from the Technical University of Darmstadt and Professor D. Baltas from the field of medical physics has decisively contributed to scientific developments in the field of brachytherapy.

Over the past years, Mr. Zamboglou and his research team have been able to expand the spectrum of treatment indications for interventional radiotherapy. The capacity of advanced image guidance and individualised dose shaping, enabled the effective application of interstitial brachytherapy for the treatment of prostate and breast cancer, sarcomas as well as brain tumour and soft tissue recurrences.

Especially in the curative treatment of prostate cancer, brachytherapy yields the same treatment results compared to radical surgery. However, the percentage of treatment related urinary incontinence is insignificant and the proportion of patients with preserved erectile function exceeds 80%.

Through progresses in the optimisation of dose distribution and advanced methods of virtual treatment simulation, Professor Zamboglou has offered advanced interventional radiotherapeutical treatment to more than 15.000 patients. He trained physicians from more than 120 institutions, including 10 centres from Greece, in his brachytherapy method.

Professor Zamboglou’s research focuses primarily on the field of image guided three dimensional treatment planning with geometry oriented optimisation of dose distribution. His work consists of physical, biomedical and technological research activities and introduced advanced biomedical imaging techniques.

  • 1991: Hanns Langendorff Price of the Medical Society for Radiation Protection, Germany
  • 1998: Price of the German Society for Senology
  • 2001: Richard-Mertens Price for Innovativ Research
  • 2002: Price of the German Society for Surgery
  • 2003: Price of the German Society for Medical Technology
  • 2009: Corresponding Member of the Academy of Athens
  • 2009: Honorary Member of the Medical Society of Limassol, Cyprus
  • 2010: “Strebel Medal for Brachytherapy” of the German, Austrian and Swiss Societies for Radiation Oncology
  • 2011: Honorary Member of the Austrian Society of Radiation Oncology
  • 2014: Alfred Breit Price of the German Society for Radiation Oncology

© German Oncology Center. All rights reserved.